Jonny’s back! In the first half of 2018 U.S. healthcare venture fundraising reached $4.5 billion. Will this strong pace pass the 2017 record of $9.1B? Series A Biopharma investments exploded by mid-year surpassing 2017 full-year totals, and the IPO markets in Biopharma continue to be wide open. Dx/Tools M&A jumped and Device M&A remained stable.
With 2018 in the rearview mirror, and the 2019 investment market taking shape, Jon will let us know what to expect for the healthcare markets. Jon will share his expertise and provide insight into:
How the 2018 healthcare landscape compares to previous years
Current and total healthcare and sector investments
Which Biopharma indications attracted the most funds
Which venture firms are most active
New and changes in trends
Exits: the trends in IPOs and M&A’s
At the end of this talk you should be informed as to who is investing, and the type of deals and exits that are likely to be executed in 2019.